SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading ...
Earlier this week, Viatris announced four pipeline milestones, including US FDA approval of its generic version of Sandostatin LAR Depot and regulatory progress on a low-dose contraceptive patch, an ...
Princeton-based Calyptus Pharmaceuticals Inc. announced Aug. 22 that it entered into an agreement with Provepharm SAS to accelerate development of its complex injectable product used in acute care ...
Regulatory action at Pharmathen’s main manufacturing site in Greece could potentially disrupt supplies of one of Cipla’s ...
We are establishing a fair value estimate of $13 per share for Viatris VTRS we don’t believe Viatris has created an economic moat. Our forecast lies on a low-single-digit top-line growth and a slight ...
Pharma major Lupin Ltd on Wednesday said it has received approval from the US health regulator for its generic version of risperidone for extended-release injectable suspension, used in the treatment ...
MUMBAI, India and NAPLES, Fla., Nov. 14, 2025 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of ...
BRIDGEWATER, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (AMRX) (“Amneal” or the “Company”) today announced the U.S. Food and Drug Administration (FDA) approval of ...
Hikma is offering triamcinolone acetonide injectable suspension in a 40mg/ml dose. The product is indicated for various inflammatory, autoimmune, hormonal and other conditions where a corticosteroid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback